Lindsay Donald, vice president of Ashuren Pharmaceutical & Healthcare, said: “The decision to rename the Pharmaceutical & Healthcare Division as ‘Ashuren Health Sciences’ was taken in order to more accurately represent our expanding global client base and to reflect our diverse international regulatory agency interactions.”